Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Evaluation of Benztropine for Cocaine Craving - 2

NCT00000333
terminatednot_applicable

Anticholinergic Burden in Schizophrenia

NCT00715377
completedphase_4

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

NCT00802100
completedphase_2

Effect of Antidepressants on Back Pain

NCT00018200

Clinical Trials (4)

Showing 4 of 4 trials
NCT00000333Phase 2

Evaluation of Benztropine for Cocaine Craving - 2

Completed
NCT00715377Not Applicable

Anticholinergic Burden in Schizophrenia

Terminated
NCT00802100Phase 4

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

Completed
NCT00018200Phase 2

Effect of Antidepressants on Back Pain

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4